机构风向标 | 三生国健(688336)2025年三季度机构持仓风向标

Core Insights - Sanofi Guojian (688336.SH) reported its Q3 2025 results, revealing that as of October 23, 2025, 10 institutional investors held a total of 536 million shares, representing 86.83% of the company's total equity [1] - The top ten institutional investors include notable firms such as Fuhua Pharmaceutical Co., Ltd. and Shanghai Xing Sheng Pharmaceutical Co., Ltd., with their combined holdings increasing by 0.14 percentage points compared to the previous quarter [1] - In the public fund sector, two funds increased their holdings, namely ICBC Credit Suisse Frontier Medical Equity A and China Europe Medical Health Mixed A, with an increase in holding ratio of 0.15% [1] Institutional Holdings - A total of 10 institutional investors disclosed their holdings in Sanofi Guojian, with a combined shareholding of 536 million shares [1] - The top ten institutional investors account for 86.83% of the total shares, indicating a strong institutional interest in the company [1] - The increase in the proportion of holdings among the top ten institutional investors suggests a positive sentiment towards the company's performance [1] Public Fund Activity - Two public funds reported an increase in their holdings during this period, reflecting a growing confidence in the company's prospects [1] - A total of 237 public funds did not disclose their holdings in this quarter, indicating potential shifts in investment strategies among these funds [1] - The specific funds that increased their holdings are focused on medical and healthcare sectors, aligning with the company's industry focus [1]